Biotechnology & Gene Editing
Where gene editing, de-extinction science, and brain-computer interfaces actually stand in clinical and commercial reality, sourced from trial data and regulatory filings rather than press-release optimism.
Latest Reporting
01
OpenAI's New Test Asks AI Agents to Read a Gel, Pick Colonies and Spot a Bad Control. The Best Score Was 66.7%.
4 min read 02Google's AMIE Meets Real Patients: What a Lancet Feasibility Study of 98 Primary Care Patients Does and Doesn't Show
3 min read 03FDA Approves Fayuvi, the First Treatment for Sanfilippo Syndrome Type A
5 min read 04Longevity Science's Reality Check: Do Rapamycin and Senolytics Actually Work?
7 min read 05Lab-Grown Organs: How Close Is Bioprinting to a Real Transplant?
7 min read 06The First mRNA Cancer Vaccine Just Cleared a Phase 3 Trial
7 min read 07AlphaFold's Drug-Design Spinoff Just Entered Human Trials
7 min read 08A CRISPR Cholesterol Therapy Just Cleared Its First Human Safety Test
7 min read 09Dire Wolves Are Real Again. Is a Woolly Mammoth Next?
7 min read 10CRISPR's Quiet Inflection Point
8 min readBrowse other topics: AI · Energy · Space · Blockchain · Climate